A carregar...
Systemic Treatment Options in Hepatocellular Carcinoma
BACKGROUND: Patients with advanced hepatocellular carcinoma (HCC) typically have poor survival outcomes. Until recently, sorafenib was the only systemic therapy option available and no agents were approved after sorafenib failure. However, rapid changes are beginning to emerge in the treatment lands...
Na minha lista:
| Publicado no: | Liver Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6883446/ https://ncbi.nlm.nih.gov/pubmed/31799201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000499765 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|